Medtronic Launches Registry Of Phased RF Ablation For AFib
This article was originally published in The Gray Sheet
Executive Summary
The European registry is the first observational “real world” study of Medtronic’s PVAC Gold multi-electrode ablation catheter.
You may also be interested in...
Global Approvals Analysis: LivaNova, Abbott, Medtronic, Boston Scientific Lead List Of January Cardio Approvals
January brought 23 non-US approvals, including 13 CE marks, according to Medtech Insight's Approvals Tracker. The total for January 2018 also exceeds the 20 non-US approvals recorded a year ago.
Safety Concerns Sink Medtronic A-Fib Catheter Ablation System At Panel
Risks associated with Medtronic’s Phased RF catheter ablation system for atrial fibrillation outweigh the benefits of the device, FDA’s Circulatory System Devices panel concluded in an 8-2 vote on Oct. 27.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.